Table 2: Distribution of ERα and PR in benign and malignant mammary tumors.

Tumor typeERα+
PR+
ERα+
PR−
ERα
PR+
ERα
PR−
Total

Benign6 (54.55%)5 (45.45%)11
Malignant1 (5.56%)9 (50%)8 (44.44%)18

Total01151329